From FDA Law Blog::

Like Ma Bell, I’ve Got the Ill Communications: Final Guidances Issued Posted: 19 Jun 2018 06:54 PM PDT By Dara Katcher Levy & Sara W. Koblitz & Jeffrey N. Wasserstein — Announced as another effort to improve patient access and address drug pricing, FDA recently finalized two guidance documents intended to facilitate better communication and negotiation with payors, formulary committees, and others: Medical Product Communications That Are Consistent With the FDA-Required Labeling – Questions and Answers: Guidance for Industry, hereinafter “Promotional Communication Guidance”; and Drug and Device Manufacturer Communications with Payors, Formulary Committees, and Similar Entities—Questions and Answers, hereinafter “Payor Communication Guidance” continue reading here